lifestyle.smarttalksuccess.com

Author: Egetis Therapeutics

Egetis Announces Grant of Patent for MCT8 Deficiency Composition in The U.S.

May 6, 2026
Egetis Therapeutics to Participate in Pediatric Endocrine Society Annual Meeting 2026

May 5, 2026
Egetis Appoints Tiago Nunes as Chief Medical Officer

May 3, 2026
Egetis Announces FDA Acceptance and Priority Review of NDA for Emcitate(R) (tiratricol) for MCT8 Deficiency

May 1, 2026
Egetis Receives Notice of Allowance for MCT8 Deficiency Composition Patent in the U.S.

April 29, 2026
Egetis Therapeutics Launches Educational Websites on MCT8 Deficiency for Physicians and Caregivers

March 2, 2026